|
FMR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.949400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.095200E-01 |
| Normal-vs-Stage2 |
4.623200E-01 |
| Normal-vs-Stage3 |
3.097200E-01 |
| Normal-vs-Stage4 |
5.227800E-01 |
| Stage1-vs-Stage2 |
5.062400E-01 |
| Stage1-vs-Stage3 |
2.830400E-01 |
| Stage1-vs-Stage4 |
6.295200E-01 |
| Stage2-vs-Stage3 |
9.188200E-01 |
| Stage2-vs-Stage4 |
8.671400E-01 |
| Stage3-vs-Stage4 |
7.514600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.099400E-01 |
| Normal-vs-AfricanAmerican |
2.562600E-01 |
| Normal-vs-Asian |
7.652600E-01 |
| Caucasian-vs-AfricanAmerican |
8.409600E-02 |
| Caucasian-vs-Asian |
7.161400E-01 |
| AfricanAmerican-vs-Asian |
2.215400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.241400E-01 |
| Normal-vs-Female |
6.416200E-01 |
| Male-vs-Female |
8.041400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.184000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.093200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.718800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.376400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.856400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.179900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.543200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.871780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.605000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.051900E-02 |
| Classical-VS-Follicular |
9.156700E-04 |
| Classical-VS-Other |
3.831200E-01 |
| Classical-VS-Normal |
6.316000E-01 |
| Tall-VS-Follicular |
6.303200E-01 |
| Tall-VS-Other |
9.877800E-01 |
| Tall-VS-Normal |
2.104800E-01 |
| Follicular-VS-Other |
8.213000E-01 |
| Follicular-VS-Normal |
6.880400E-02 |
| Other-VS-Normal |
5.078400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.859350E-01 |
| Normal-vs-N1 |
6.464800E-01 |
| N0-vs-N1 |
5.110200E-01 |
|
|
